Asia, 35, 196, 208

see also specific countries

immigrants from, 50, 51

insecticides as means of suicide, 280

Assisted suicide, 21, 44

Association of Poison Control Centers, 287

Attitudes and beliefs, 6, 70, 89-90, 204, 230, 316, 349-350, 351, 352-353

see also Depression;

Guilt and shame;

Religious influences;

Self-efficacy and self-esteem;

Social and cultural factors;

Stigma;

Temperament

clergy, 257

correctional institution staff, 358, 359

discrimination,

gender-based, 209-210

racial/ethnic, 209-210, 214, 215, 332-334 , 355, 358-359

gatekeeper training, 299

school-based prevention programs, 294-295

Australia, 36, 39, 50, 81, 134, 164, 196, 207, 208, 256, 278, 285, 312

Austria, 35, 196, 278, 279-280, 288, 296

Auto exhaust, 19, 288-289

Autopsies, see Brain and brain repositories;

Coroners and medical examiners;

Psychological autopsies;

Tissue samples

Beck Anxiety Scale, 231

Beck Depression Inventory, 231, 400

Beck Hopelessness Scale, 231

Befrienders International Centers, 289, 290

Benzodiazepines, 242

Bereavement, 4, 13, 19, 22

elderly persons, 42, 352

widows and widowers, 3, 23, 198, 204, 352

Big Horn Center for Public Policy, 303

Biological factors, x, 2, 119-155, 213-215, 424, 426, 429, 431-432

see also Brain and brain repositories;

Genetic factors;

Neurochemistry;

Pharmaceuticals

biological markers, 230

childhood trauma, 158, 170-172, 184

physiological stress system, 26, 75, 77, 89, 92, 94, 119, 120-122, 130, 131, 140

psychological autopsies and, 378

violence, 119, 120, 122, 125, 126, 128, 131, 136, 138, 140, 235-236, 241

Bipolar disorder, 71, 73, 346

see also Depression

adolescents and youth, 87

electroconvulsive therapy, 242-243

inpatient care, 251

lithium treatment, 4, 233-235, 253, 348

mood stabilizers, 233-236, 253, 346, 348, 350

serotonin, 125

time factors, 74, 254

Black persons, see African-Americans

Borderline personality disorder, 79-81

Brain and brain repositories, 10, 119, 120, 123-124, 127-130, 139-149, 425-426 , 428, 429

see also Hypothalamic-pituitary-adrenal axis;

Neurochemistry;

Serotonin

antidepressants, negative effects, 240

cerebrospinal fluid, 123, 124-126

childhood trauma, 158, 171-173, 181-182

noradrenergic system, 122, 128-129, 140

psychological autopsies and, 378

Britain, see United Kingdom

Call to Action, 27, 436

Canada, 35, 47, 48, 57, 207, 278, 284, 309-310 , 344

Carbamazepine, 235

Case-control studies, 142, 309, 356, 402

Case management, 254

Catecholamine, 92, 172

Center for Studies of Suicide Prevention, see Suicide Research Unit

Center for the Study and Prevention of Suicide , 306

Centers for Disease Control and Prevention (CDC), 1, 9, 12, 14, 19-20, 307, 308

Internet site, 57

media coverage of suicides, 278

research centers, 406, 410, 411

surveillance, 12-13, 303, 382, 384, 385- 386, 387, 433-434

Cerebrospinal fluid, 123, 124-126

Child abuse, 4, 80, 158-159, 162-164, 174-178 , 182, 297, 432

memory of lacking, 163, 175

post-traumatic stress disorder, 172, 173

Front Matter (R1-R16)

Executive Summary (1-16)

1 Introduction (17-32)

2 Magnitude of the Problem (33-68)

3 Psychiatric and Psychological Factors (69-118)

4 Biological Factors (119-156)

5 Childhood Trauma (157-192)

6 Society and Culture (193-228)

7 Medical and Psychotherapeutic Interventions (229-272)

8 Programs for Suicide Prevention (273-330)

9 Barriers to Effective Treatment and Intervention (331-374)

10 Barriers to Research and Promising Approaches (375-422)

11 Findings and Recommendations (423-438)

Appendix A: Statistical Details (439-468)

Appendix B: Consultants (469-471)

Appendix C: Workshop Agendas (472-474)

Index (475-496)